Serum and plasma contain natural serine protease inhibitors and proteins that bind to Lipid A, causing significant low endotoxin recovery or masking effects.
Endotoxins are the primary pyrogenic contaminants in gram-negative bacterial systems. Endotoxin detection is traditionally centered on the Limulus Amebocyte Lysate (LAL) assay, a complex enzymatic cascade derived from the horseshoe crab that reacts specifically with the Lipid A moiety of the endotoxin. However, as biologics complexity, the off-the-shelf LAL kit often fails. At Creative Biolabs, we bridge this gap by developing customized assay kits that account for sample-specific interference, ensuring that every endotoxin unit (EU) is accurately accounted for.
Standard LAL kits often struggle with complex biological matrices, leading to two major problems: inhibition (false negatives) and enhancement (false positives).
Serum and plasma contain natural serine protease inhibitors and proteins that bind to Lipid A, causing significant low endotoxin recovery or masking effects.
Many vaccines utilize aluminum salts or oil-in-water emulsions. These components can physically sequester endotoxins or interfere with the optical clarity required for kinetic assays.
The presence of hydrophobic cytotoxic payloads and specific linkers often necessitates the use of organic solvents or surfactants, which can denature LAL enzymes and suppress the reaction cascade.
Concentrated IgG solutions can increase viscosity and create non-specific interactions with the lysate proteins, disrupting the timing of the enzymatic trigger.
Creative Biolabs offers a suite of detection platforms tailored to your laboratory's infrastructure and sensitivity needs:
Developed for high-throughput automated systems, providing a linear range of detection down to 0.001 EU/mL.
Optimized for samples with inherent color interference that might disrupt chromogenic readings.
We develop animal-free, synthetic assays for clients seeking sustainable, sustainable, and highly specific detection without the interference of (1→3)-β-D-glucans.
Custom-formulated solutions containing specific chelators and non-ionic surfactants to dissociate protein-LPS complexes prior to detection.
We provide bulk core reaction solutions (e.g., lysate, chromogenic substrate) for diagnostic reagent manufacturers who require high-consistency raw materials for their own internal kit production.
We customize the color development rate, sensitivity thresholds, and linear ranges specifically for your laboratory's instrument systems, ensuring seamless integration.
At Creative Biolabs, we specialize in tailoring LAL and rFC formulations to overcome the specific interference challenges of complex biologics. our endotoxin detection kit development service follows a rigorous, phase-gate workflow designed to transition from initial matrix analysis to a fully validated, regulatory-compliant diagnostic tool.
Our endotoxin detection kit development service helps you achieve reproducible, high-sensitivity quantification through tailored reagent formulations and optimized reaction kinetics. Creative Biolabs ensures your diagnostic tools are perfectly calibrated to your specific molecular matrix, streamlining your path to clinical validation. Contact us to discuss your specific project requirements.
LER occurs when endotoxins become "masked" by certain buffers or proteins. Our custom kits include specific "unmasking" agents that release these endotoxins for accurate detection.
Yes, we often switch to turbidimetric or rFC (fluorescence) platforms for samples that interfere with chromogenic absorbance.
While the core LAL technology remains the same, we provide the validation data you need to prove to regulatory bodies that your specific matrix is being measured accurately.
We are leaders in rFC kit development, providing a sustainable and more specific alternative to traditional LAL.
We develop specialized dilution buffers and high-salt-tolerant lysate formulations to maintain enzyme activity.